Concepedia

Atsushi Osada

AO

Statistics

Publications

13

Citations

380

H-Index

13

Active since

1960

Affiliations

NanoCarrier (Japan)(Current)

University of Yamanashi

Duke Medical Center

UNC Lineberger Comprehensive Cancer Center

University of Yamanashi Hospital

Atsushi Osada is an author at NanoCarrier (Japan) specializing in oncology, medicine, and pharmacology.

Publications per year

1960–2022

13

Publications

13

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

Vivek Subbiah, Juneko E. Grilley‐Olson, Austin J. Combest et al. · Clinical Cancer Research · 2017 · 112 citations

Medicine, Oncology, Pharmacology +15

Up-Regulation of CD44 Expression by Tumor Necrosis Factor-α Is Neutralized by Interleukin-10 in Langerhans Cells

Atsushi Osada, Hideki Nakashima, Masutaka Furue et al. · Journal of Investigative Dermatology · 1995 · 36 citations · Full text

Life Sciences, Cell Biology, Immunology +12

A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma

Sant P. Chawla, Sanjay Goel, Warren Chow et al. · Clinical Cancer Research · 2020 · 36 citations

Pharmacy, Oncology, Pharmacology +17

Treatment of plasma cell cheilitis with griseofulvin

Kunihiko Tamaki, Atsushi Osada, Katsuhiko Tsukamoto et al. · Journal of the American Academy of Dermatology · 1994 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +2

A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer

Simona Ruxandra Volovăț, Tudor–Eliade Ciuleanu, P. Koralewski et al. · Oncotarget · 2020 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 13